Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Harvard Scientific's impotence drug advances in European trials

Feb. 13, 1997

IND filed for novel HIV treatment from Steroidogenesis Inhibitors

Feb. 13, 1997

FDA approves product for hemophilia

Feb. 13, 1997

MGI Pharma seeks FDA approval of new indication for Salagen Tablets

Feb. 12, 1997

Novartis launches once-daily hypertension Rx

Feb. 12, 1997

NexMed licenses alprostadil cream

Feb. 12, 1997

Tretinoin gel cleared for marketing by FDA

Feb. 11, 1997

Cypress awarded grant for research related to its PROSORBA Column

Feb. 7, 1997

Alza signs licensing agreements for transdermal testesterone products

Feb. 7, 1997

First Corlopam Renal Program study completed

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...